SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950120-08-000484
Filing Date
2008-09-29
Accepted
2008-09-29 16:59:00
Documents
1
Period of Report
2008-09-23

Document Format Files

Seq Description Document Type Size
1 gellerform3_092908ex.html 3  
1 gellerform3_092908ex.xml 3 3787
  Complete submission text file 0000950120-08-000484.txt   5535
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Issuer) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 248 CENTRAL PARK WEST NEW YORK NY 10024
Business Address (917)509-6062
Geller Matthew (Reporting) CIK: 0001446201 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-19879 | Film No.: 081095072